StocksFin Logo
AVEO logo
$AVEO

AVEO Pharmaceuticals, Inc.

AVEO country of incorporation
|
https://www.aveooncology.com
|
Mr. Michael Bailey
|
114 employees
NASDAQ | Healthcare | Biotechnology
AVEO reported its Q322 earnings on November 7, 2022 (104 weeks ago).
$30.45M 100.7% vs. Q321 Revenues Q322
86.98% -1.7% vs. Q321 Gross Profit Margin
-10.73% ! 84.3% vs. Q321 Net Profit Margin
194k 102.4% vs. Q321 Free Cash Flow Q322
$-0.09 ! 70% vs. Q321 EPS Q322
Company Card Q322
As reported on November 7, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B
Growth calculated YoY
Company Card Q322
As reported on November 7, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B
Growth calculated YoY
Overview
Income Statement
Full Income Statement
Period Net Revenue Cost of Revenue Net Profit EPS
FY2022 Not reported yet.
Q32022
30.45M
+20.3%
3.96M
-3.27M
+60.7%
$-0.09
Q22022
25.3M
+21%
3.07M
-8.32M
+18.4%
$-0.24
Q12022
20.92M
2.43M
-10.2M
$-0.3
FY2021
38.87M
 4.74M
-53.34M
$-2.49
Q42021
-8.5M
-156%
2.03M
-7.26M
+30%
$-0.21
Q32021
15.17M
+100.8%
1.74M
-10.37M
+23.7%
$-0.3
Q22021
7.56M
+293.5%
822k
-13.6M
+38.5%
$-0.4
Q12021
1.92M
138k
-22.12M
$-0.81
FY2020
6.02M
 0
-35.58M
$-1.66
FY2019
28.8M
 0
9.39M
$0.61
FY2018
5.41M
 0
-5.33M
$-0.4
Balance Sheet
Full Balance Sheet
Period Total Assets Total Liabilities Cash & Eq. Debt Stock Equity
FY2022 Not reported yet.
Q32022
101.23M
 72.39M
77.4M
38.68M
28.85M
Q22022
98.11M
 67.52M
70.17M
38.43M
30.59M
Q12022
98.22M
 61.27M
73.85M
38.2M
36.94M
FY2021
105.34M
 59.47M
70.54M
22k
45.87M
FY2020
66.91M
 31.62M
61.76M
15.57M
35.29M
FY2019
50.6M
 35.75M
29.79M
25.34M
14.85M
FY2018
27.94M
 55.16M
24.43M
22.29M
-27.23M
Cash Flow Statement
Full Cash Flow Statement
Period Operating CF Investing CF Financing CF Capex Free Cash Flow
FY2022 Not reported yet.
Q32022
194k
 7M
36k
0
194k
+107.9%
Q22022
-2.45M
 -1.79M
561k
0
-2.45M
+70.2%
Q12022
-8.22M
 11.52M
0
0
-8.22M
FY2021
-57.26M
 -16.87M
82.9M
0
-57.26M
FY2020
-37.98M
 17.7M
52.26M
-363k
-38.35M
FY2019
-2.92M
 -17.92M
26.19M
0
-2.92M
FY2018
-25.03M
 18.58M
15.93M
0
-25.03M
Institutional Ownership
Dividend History
No dividend history.
Number of Employees